Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation

Ophthalmic Research

Volumn 34, Issue 1, 2002, Pages 43-47

  Umeda, Naoyasu ^a   Ozaki, Hiroaki ^a   Hayashi, Hideyuki ^a   Kondo, Hiroyuki ^a   Uchida, Hiroko ^a   Oshima, Kenji ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Hepatocyte growth factor; Ocular angiogenesis; Proliferative diabetic retinopathy; Proliferative vitreoretinopathy; Vascular endothelial growth factor

Indexed keywords

SCATTER FACTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE; FEMALE; HUMAN; HUMAN TISSUE; IRIS; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; RETINA; RETINA MACULA HOLE; VITREOUS BODY;

DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IRIS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 0036170467     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048324     Document Type: Article

References (36)

1. Retinal neovascularization in health and disease
2. Retinal neovascularization
3. Angiogenic factor in human ocular fluid
4. Basic fibrobrast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
5. Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management
6. Insulin-like growth factor in the vitreous
7. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease: Studies in nondiabetic and diabetic subjects
8. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
9. Increase vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
10. Immunodetection of vascular endothelial growth factor in the vitreous of eyes with proliferative diabetic retinopathy
11. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy
12. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders
13. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy
14. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model
15. Inhibition of vascular endothelial growth factor reduces retinal neovascularization in the mouse
16. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbit and primates
17. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
18. Scatter factor induces blood vessel formation in vivo
19. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo
20. Hepatocyte growth factor/scatter factor modulates cell motility, proliferation, and proteoglycan synthesis of chondrocytes
21. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats
22. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration
23. Interactions between scatter factors and their receptors: Hints for therapeutic applications
24. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor
25. Scatter factor stimulates tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice
26. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: Additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor
27. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy
28. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity
29. The classification of retinal detachment with proliferative vitreoretinopathy
30. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization
31. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor
32. Blockage of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization
33. Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor
34. Hepatocye growth factor receptor in human RPE Cells: Implications in proliferative vitreoretinopathy
35. Effectof vitreous on morphologic characteristics of retinal pigment epithelial cells: A new approach to the study of proliferative vitreoretinopathy
36. Hepatocyte growth factor/Scatter factor in the eye